文献速递中毒与环境急症心脑血管急症重症综合管理与镇静镇痛

4-氟苯丙胺暴露后死亡、脑出血及严重心血管毒性:前瞻性队列研究

Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: A Prospective Cohort Study.
PubMed 文献 · Ann Emerg Med · 2017-09-29
一句话结论4-氟苯丙胺暴露患者中严重毒性比例较高,报告2例死亡、4例脑出血及多种严重心血管事件,作者建议警告使用者相关风险。

该前瞻性队列研究纳入2016年荷兰毒物信息中心接诊的45例4-氟苯丙胺暴露患者,通过标准化问卷电话随访医生和/或患者,并用液相和气相色谱-质谱技术检测药物样本和生物样本。所有患者均出现不良反应,8例报告严重毒性,其中5例在生物标本中确认4-氟苯丙胺暴露。严重毒性包括2例死亡、4例脑出血(1例致死)、2例倒置型Takotsubo心肌病、1例心肌梗死、1例急性心力衰竭,以及普遍存在的显著高血压和心动过速。作者认为该人群中严重毒性比例相对较大,应警告使用者4-氟苯丙胺的风险。

要点

  • 45例4-氟苯丙胺暴露患者中8例出现严重毒性,包括2例死亡、4例脑出血(1例致死)。
  • 严重毒性还包括2例倒置型Takotsubo心肌病、1例心肌梗死、1例急性心力衰竭。
  • 所有患者均出现不良反应,整体高血压和心动过速发生率高。
  • 8例严重毒性中5例在生物标本中确认4-氟苯丙胺暴露。
  • 作者认为该人群严重毒性比例相对较大,应警告使用者4-氟苯丙胺的风险。

适用人群与场景

  • 2016年荷兰毒物信息中心经医生咨询的所有报告4-氟苯丙胺暴露的患者。

红旗征与不能漏的情况

  • 严重毒性包括死亡、脑出血(含致死性)、倒置型Takotsubo心肌病、心肌梗死、急性心力衰竭,以及显著高血压和心动过速。

研究设计与关键结果

  • 前瞻性队列研究纳入45例4-氟苯丙胺暴露患者,33例完成医生和/或患者随访。
  • 所有患者均出现不良反应;8例报告严重毒性,其中5例在生物标本中确认4-氟苯丙胺暴露。
  • 严重毒性包括2例死亡、4例脑出血(1例致死)、2例倒置型Takotsubo心肌病、1例心肌梗死、1例急性心力衰竭,以及整体高发的显著高血压和心动过速。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,4-氟苯丙胺使用者应被警告该物质的风险。
  • 作者指出,自2007年4-氟苯丙胺进入荷兰毒品市场以来使用持续增加,使用者可能因其被感知为「轻量摇头丸」而认为相对安全。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: We study adverse health effects after use of the new psychoactive substance 4-fluoroamphetamine.

METHODS: All patients who reported 4-fluoroamphetamine exposure and for whom the Dutch Poisons Information Center was consulted by their physician in 2016 were included in a prospective cohort study. The clinical course was investigated through telephone interviews with the physician and/or patient, using standardized questionnaires. 4-Fluoroamphetamine was analyzed in remaining drug material and biological samples with liquid and gas chromatography-mass spectrometry techniques.

RESULTS: We included 45 patients, and follow-up with the physician and/or patient was performed in 33 cases. All patients experienced adverse effects after 4-fluoroamphetamine use. Severe toxicity was reported in 8 patients. In 5 of these patients, 4-fluoroamphetamine exposure was confirmed in biological specimens. Severe toxicity that was reported included 2 fatalities, 4 patients with cerebral hemorrhage (1 fatal), 2 patients with inverted Takotsubo's cardiomyopathy, 1 patient with myocardial infarction, 1 patient with acute heart failure, and an overall high prevalence of pronounced hypertension and tachycardia.

CONCLUSION: Since the introduction of 4-fluoroamphetamine to the Dutch drug market in 2007, its use continues to increase, possibly because users perceive it as "ecstasy light" and thus relatively safe. However, the proportion of patients with severe toxicity after 4-fluoroamphetamine use is relatively large in our study population. Therefore, users should be warned about the risks of 4-fluoroamphetamine.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Hondebrink L, Nugteren-van Lonkhuyzen JJ, Rietjens SJ, et al. Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: A Prospective Cohort Study. Ann Emerg Med. 2017. PMID: 28969928. doi:10.1016/j.annemergmed.2017.07.482

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。